Delivery Order SPE2DB20D9354-SPE2DB25FX7Y2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,940.55 to DMS Pharmaceutical Group Inc. for Botox 200-unit vials. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a pharmaceutical supply requirement fulfilled through DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete on an...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Botox 200 unit vials valued at $7,115.35. This firm fixed-price delivery order represents a single procurement issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at $499,999,999 and extending through November 2026. The order is set to complete by October 21, 2025, with fulfillment occurring from the vendor's Park Ridge, Illinois...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,762.20 to DMS Pharmaceutical Group Inc. for the supply of BOTOX 200 Unit Vials, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $18,502.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The delivery order carries a firm fixed-price structure with an ultimate completion date of September 19, 2025, and was processed without a set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a $4,625.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Botox 100 unit vials, with an ultimate completion date of October 17, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at $500 million and...
- The Defense Logistics Agency awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 Unit Vials. The contract was awarded on September 24, 2025, with an ultimate completion date of October 16, 2025, and operates under firm fixed-price terms. This delivery order was issued without a set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Illinois location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,174.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The award was issued on September 15, 2025, with an ultimate completion date of October 6, 2025, under a firm fixed-price contract structure with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, issued under firm fixed-price terms with an ultimate completion date of September 4, 2025, represents a specific purchase order executed without set-aside designation. DMS Pharmaceutical Group, registered in the System for Award Management since...
- The Defense Logistics Agency awarded a $64,685 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The award, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. This delivery order is issued under DMS...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB25FX7Y2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc. for BOTOX 200 Unit Vials, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a purchase order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue delivery orders for pharmaceutical products supporting military health facilities nationwide. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's contract portfolio with DLA demonstrates significant experience delivering specialized pharmaceutical products including oncology treatments, vaccines, and injectable medications. This delivery order for BOTOX reflects the company's established capability to supply specialty pharmaceutical products to support the medical requirements of military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 9/4/25 |